ArticleMolecular and clinical oncology2017

Urine metabolomics as a predictor of patient tolerance and response to adjuvant chemotherapy in colorectal cancer.

Mark A Dykstra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.